Subscribe
News
Latest News
Post a Press Release
View Press Releases
Submit a Story
Reprint Articles
Advertise
Media Kit
Digital Advertising Opportunities
Lead Generation
Whitepapers
Webinars
Podcasts
Editorial Calender
Free Downloads
Whitepapers
Podcasts
Webinars
Inside Ebooks
Events
Webinars
Industry Events
Dx Conferences
Tri-Conference
Next Generation Dx
Dx Innovation Summit
About
Editorial Profile
Editorial Calender
Contact
Molecular Med Tri-Conference
Latest News
Exosome Dx Aiming to Commercialize Liquid Biopsies Seeks 25M
January 28, 2015 |
Cambridge, MA-based Exosome Diagnostics aims to raise $25 million, on top of the $27 million in Series B funding it raised last March. Exosome would use the cash to launch its first two products: a blood-based test for lung cancer, and a urine test for prostate cancer.
Xconomy